Clinical Trials Directory

Trials / Completed

CompletedNCT03101150

Effect of Vitamin D3 Supplementation in Pregnancy on Risk of Pre-eclampsia

Effect of Antenatal Vitamin D3 Supplementation on Risk of Pre-eclampsia

Status
Completed
Phase
Phase 1 / Phase 2
Study type
Interventional
Enrollment
179 (actual)
Sponsor
King Fahad Medical City · Other Government
Sex
Female
Age
20 Years – 40 Years
Healthy volunteers
Accepted

Summary

Vitamin D deficient pregnant ladies were selected and randomized into 2 groups for routine daily dose of multivitamin (400IU vitamin D3) versus maximum safest treatment daily dose (4000IU vitamin D3). Participants were assessed and compared for number of pre-eclampsia cases.

Detailed description

Vitamin D3 has key role in decidualization and implantation of placenta.Vitamin D deficiency is thought to have positive association with pre-eclampsia.Vitamin D deficiency is highly prevalent in some parts of the world and it is not universally screened antenatally. Pre-eclampsia is a known multifactorial pregnancy disorder with significant maternal and perinatal morbidity and mortality. Vitamin D3 has a down-regulating effect on inflammatory pathways and reducing endothelial cell damage. Investigators want to assess in vitamin D deficient group whether treatment reduces the risk of pre-eclampsia.

Conditions

Interventions

TypeNameDescription
DRUG400 IU Vitamin D3Antenatal multivitamin
DRUG4000 IU Vitamin D34000 IU Vitamin D3 (cholecalciferol) daily = 40 drops daily

Timeline

Start date
2012-10-01
Primary completion
2014-10-31
Completion
2015-12-31
First posted
2017-04-04
Last updated
2018-11-02
Results posted
2018-11-02

Source: ClinicalTrials.gov record NCT03101150. Inclusion in this directory is not an endorsement.